The American College of Rheumatology similarly released updated recommendations on LN in May.
Support for the development of the EULAR/ERA-EDTA recommendations was provided via grants from the EULAR Standing Committee on Clinical Affairs and the ERA-EDTA. The authors reported having no competing interests.